Finding the cause of angina in patients without obstructed coronaries can reassure patients and lead to tailored therapy.
Hosted on MSN16m
Artivion (NYSE:AORT) Misses Q4 Sales TargetsMedical device company Artivion (NYSE:AORT) in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback